Apyx Medical (APYX) Total Current Liabilities (2010 - 2026)

Apyx Medical's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $9.4 million for Q1 2026.

• Quarterly Total Current Liabilities fell 0.66% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (down 0.66% YoY) and the FY2025 annual result came in at $11.7 million, up 9.13% from the prior year.
• Total Current Liabilities was $9.4 million for Q1 2026 at Apyx Medical, down from $11.7 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $19.0 million in Q2 2023 and bottomed at $9.4 million in Q1 2026.
• A 5-year average of $11.8 million and a median of $11.0 million in 2025 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 67.63% — and 2024, when it plunged 44.09%.
• Apyx Medical's Total Current Liabilities stood at $11.8 million in 2022, then climbed by 7.51% to $12.7 million in 2023, then dropped by 15.85% to $10.7 million in 2024, then rose by 9.13% to $11.7 million in 2025, then decreased by 19.26% to $9.4 million in 2026.
• Business Quant data shows APYX's Total Current Liabilities at $9.4 million in Q1 2026, $11.7 million in Q4 2025, and $11.0 million in Q3 2025.